Fifth Third Bancorp
- SEC CIK
- 0000035527
- Latest filing
- Aug 5, 2026
CANF holding history
Can-Fite BioPharma Ltd. in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CANF overviewAll 13F holders of CANFFull Q2 2026 holdings
- Shares (Q2 2026)
- 150
- Value
- $446
- % of portfolio
- <0.1%
- Quarters held
- 20
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 150 | $446 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 150 | $465 | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q4 2025 | 3,000 | $600 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 3,000 | $1.86K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 3,000 | $3.15K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 3,000 | $4.44K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 3,000 | $4.88K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 3,000 | $6.03K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3,000 | $7.74K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3,000 | $6.66K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,000 | $6.60K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 3,000 | $7.95K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3,000 | $9.21K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 3,000 | $6.87K | <0.1% | 00.0% | UnchangedConverted for a 1-for-10 split | Holders |
| Q4 2022 | 30,000 | $18.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 30,000 | $23.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 30,000 | $28.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 30,000 | $37.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 30,000 | $39.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 30,000 | $50.0K | <0.1% | +30,000 | New | Holders |